Overview of skin cancer detection and prevention for the primary care physician

Mayo Clinic Proceedings

Volumn 75, Issue 5, 2000, Pages 491-500

  Bruce, Alison J ^a,b   Brodland, David G ^a,b  

^a MAYO CLINIC ROCHESTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER PREVENTION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FAMILY HISTORY; HUMAN; INCIDENCE; MELANOMA; MORBIDITY; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RISK FACTOR; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

EID: 0034099491     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64218-3     Document Type: Article

References (34)

1. Marks R. An overview of skin cancers: incidence and causation. Cancer. 1995:75(suppl):6()7-612.
2. Kopf AW. Salopek TG. Slade J. Marghoob AA. Bart RS. Techniques of cutaneous examination for the detection of skin cancer. Cancer. 1995:75(suppl):684-690.
3. Shenefelt PD. Skin cancer prevention and screening. Prim Cure. 1992:19:557-574.
4. Osterlind A. Etiology and epidemiology of melanoma and skin neoplasms. CHIT Opin Oncol. 1991:3:355-359.
5. Landis SH. Murray T. Bolden S. Wingo PA. Cancer statistics, 1998 [published corrections appear in CA Cancer J Clin. 1998:48:192 and 1998:48:329]. CA Cancer J Clin. 1998:48:6-29.
6. Friedman RJ. Rigel DS. Silverman MK. Kopf AW. Vossaert KA. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1991:41:201226.
7. Kopf AW. Rigel DS. Friedman RJ. The rising incidence and mortality rate of malignant melanoma.,J Dermatol Sun; Oncol. 1982:8: 760-761.
8. Rigel DS. New York University Co-operative Group. Cancer statistics. CA Cancer J Clin. In press.
9. Austoker J. Melanoma: prevention and early diagnosis. BMJ. 1994:308:1682-1686.
10. Gloster HM Jr. Brodland DG. The epidemiology of skin cancer. Dermatol Surg. 1996:22:217-226.
11. Rhodes AR. Public education and cancer of the skin: what do people need to know about melanoma and nonmelanoma skin cancer? Cancer. 1995:75(suppl):613-636.
12. Goldstein AM. Tucker MA. Etiology, epidemiology, risk factors, and public health issues of melanoma. CHIT Opin Oncol. 1993: 5:358-363.
13. Pariser DM. Phillips PK. Basal cell carcinoma: when to treat it yourself, and when to refer. Geriatrics. 1994:49:39-44.
14. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of Nonmelanoma Skin Cancer in the United Stales. Bethesda, Md: US Dept of Health and Human Services, National Institutes of Health; 1983. Publication NIH 83-2433.
15. Rampen FH. Neumann HA, Kiemeney LA. Fundamentals of skin cancerJmelanoma screening campaigns. Clin Exp Dermatol. 1992; 17:307-312.
16. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer, I: basal cell carcinoma. Arch Dermatol. 1995; 131:157-163.
17. Gallagher RP, Hill GB, Bajdik CD. et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer, II: squamous cell carcinoma. Arch Dermatol. 1995;131:164169.
18. Marks R, Rennie G, Selwood T. The relationship of basal cell carcinomas and squamous cell carcinomas to solar kératoses. Arch Dermatol. 1988; 124:1039-1042.
19. Osterlind A. Epidemiology on malignant melanoma in Europe. Acta Oncol. 1992;31:903-908.
20. Koh HK, Geller AC, Miller DR, Lew RA. The early detection of and screening for melanoma: international status. Cancer. 1995; 75(suppl):674-683.
21. Johnson N, Mant D, Newton J, Yudkin PL. Role of primary care in the prevention of malignant melanoma. Br .1 Gen Pract. 1994:44: 523-526.
22. Ross PM. Apparent absence of a benign precursor lesion: implications for the pathogenesis of malignant melanoma. J Am Acad Dermatol. 1989;21:529-538.
23. Marks R, Dorevitch AP, Mason G. Do all melanomas come from "moles"? a study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol. 1990; 31:77-80.
24. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J Invest Dermatol. 1994; 102:4S-5S.
25. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection..J Am Acad Dermatol. 1992;26:976-990.
26. Elder DE. Skin cancer: melanoma and other specific nonmelanoma skin cancers. Cancer: 1995;75(suppl):245-256.
27. Ridgeway CA, Hieken TJ, Ronan SG, Kim DK, Das Gupta TK. Acral lentiginous melanoma. Arch Surg. 1995; 130:88-92.
28. Sober AJ, Burstein JM. Precursors to skin cancer. Cancer. 1995; 75(suppl):645-650.
29. Zugerman C. Diagnosis and management of skin cancer. Compr Ther. 1991; 17:17-22.
30. Holmstrom H. Surgical management of primary melanoma. Scmin SurgOncol. 1992:8:366-369.
31. Lookingbill DP. Yield from a complete skin examination: findings in 1157 new dermatology patients. J Am Acad Dermatol. 1988; 18:31-37.
32. Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neidner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995; 131:170-175.
33. Thompson SC, Jolley D, Marks R. Reduction of solar kératoses by regular sunscreen use. N Engt J Med. 1993;329:1147-1151.
34. Drolet BA, Connor MJ. Sunscreens and the prevention of ultraviolet radiation-induced skin cancer. J Dermatol Surg Oncol. 1992; 18: 571-576.